Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, blocking access to the study record content. The additions include the 403 message and standard site header/footer, indicating restricted access to the content.
    Difference
    20%
    Check dated 2026-09-20T22:34:22.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a minor page version update rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-30T21:54:08.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, signaling a new build of the study page. No changes to the study details or displayed information are evident.
    Difference
    0.0%
    Check dated 2026-08-09T12:16:58.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page shows an updated revision tag to Revision: v3.6.4, reflecting an internal update to the study record. There is no indication of changes to trial content or data in this update.
    Difference
    0.0%
    Check dated 2026-07-25T23:54:27.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    The page shows a software revision from v3.6.2 to v3.6.3, indicating a routine site update.
    Difference
    0.0%
    Check dated 2026-07-04T13:05:58.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    A new page revision (v3.6.2) was added, replacing the previous version (v3.6.0); this appears to be a deployment or formatting update rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-06-27T05:34:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.